Literature DB >> 20306458

The impact of rapid aneuploidy detection (RAD) in addition to karyotyping versus karyotyping on maternal quality of life.

E M A Boormans1, E Birnie, D Oepkes, C M Bilardo, H I J Wildschut, J Creemers, G J Bonsel, J M M van Lith.   

Abstract

OBJECTIVE: To assess the impact of rapid aneuploidy detection (RAD) combined with fetal karyotyping versus karyotyping only on maternal anxiety and health-related quality of life.
METHODS: Women choosing to undergo amniocentesis were selected into group 1, i.e. receiving a karyotype result only (n = 132) or to group 2, i.e. receiving both the result of RAD and karyotyping (n = 181).
RESULTS: There were no systematic differences in time of RAD combined with karyotyping versus karyotyping only in terms of anxiety (P = 0.91), generic physical health (P = 0.76, P = 0.46), generic mental health (P = 0.52, P = 0.72), personal perceived control (P = 0.91) and stress (P = 0.13). RAD combined with karyotyping reduced anxiety and stress two weeks earlier compared to karyotyping only.
CONCLUSION: RAD as add-on to karyotyping reduces anxiety and stress in the short term but it does not influence overall anxiety, stress, personal perceived control, and generic mental and physical health when compared to a karyotype-only strategy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20306458     DOI: 10.1002/pd.2486

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  Rapid aneuploidy detection or karyotyping? Ethical reflection.

Authors:  Antina de Jong; Wybo J Dondorp; Daniëlle R M Timmermans; Jan M M van Lith; Guido M W R de Wert
Journal:  Eur J Hum Genet       Date:  2011-06-01       Impact factor: 4.246

2.  Is routine karyotyping required in prenatal samples with a molecular or metabolic referral?

Authors:  Angelique Ja Kooper; Jacqueline Jpm Pieters; Brigitte Hw Faas; Lies H Hoefsloot; Ineke van der Burgt; Hans A Zondervan; Arie Pt Smits
Journal:  Mol Cytogenet       Date:  2012-01-27       Impact factor: 2.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.